Another immune checkpoint, TIM3, has been found to be up-regulated on NK cells from patients with melanoma (46), gastric cancer (47) and lung adenocarcinoma (48), and blockade of TIM3 has been reported to release the exhaustion of NK cells from advanced melanoma patients in vitro (46). This evidence concerns the gene HAVCR2 and lung adenocarcinoma.